TY  - CONF
AU  - Sojic-Rajcić, J.
AU  - Rasković, Sanvila
AU  - Tomić-Spirić, Vesna
AU  - Peri'-Popadić, Aleksandra
AU  - Đurić, Vojislav
AU  - Radulović, D.
AU  - Miličić, Biljana
AU  - Bogić, M.
PY  - 2016
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/2096
PB  - Wiley-Blackwell, Hoboken
C3  - Allergy
T1  - Diagnosis and prevention of non-allergic hypersensitivity reactions caused by iodinated contrast media-our expirience
VL  - 71
SP  - 51
EP  - 51
UR  - https://hdl.handle.net/21.15107/rcub_smile_2096
ER  - 

@conference{
author = "Sojic-Rajcić, J. and Rasković, Sanvila and Tomić-Spirić, Vesna and Peri'-Popadić, Aleksandra and Đurić, Vojislav and Radulović, D. and Miličić, Biljana and Bogić, M.",
year = "2016",
publisher = "Wiley-Blackwell, Hoboken",
journal = "Allergy",
title = "Diagnosis and prevention of non-allergic hypersensitivity reactions caused by iodinated contrast media-our expirience",
volume = "71",
pages = "51-51",
url = "https://hdl.handle.net/21.15107/rcub_smile_2096"
}

Sojic-Rajcić, J., Rasković, S., Tomić-Spirić, V., Peri'-Popadić, A., Đurić, V., Radulović, D., Miličić, B.,& Bogić, M.. (2016). Diagnosis and prevention of non-allergic hypersensitivity reactions caused by iodinated contrast media-our expirience. in Allergy
Wiley-Blackwell, Hoboken., 71, 51-51.
https://hdl.handle.net/21.15107/rcub_smile_2096

Sojic-Rajcić J, Rasković S, Tomić-Spirić V, Peri'-Popadić A, Đurić V, Radulović D, Miličić B, Bogić M. Diagnosis and prevention of non-allergic hypersensitivity reactions caused by iodinated contrast media-our expirience. in Allergy. 2016;71:51-51.
https://hdl.handle.net/21.15107/rcub_smile_2096 .

Sojic-Rajcić, J., Rasković, Sanvila, Tomić-Spirić, Vesna, Peri'-Popadić, Aleksandra, Đurić, Vojislav, Radulović, D., Miličić, Biljana, Bogić, M., "Diagnosis and prevention of non-allergic hypersensitivity reactions caused by iodinated contrast media-our expirience" in Allergy, 71 (2016):51-51,
https://hdl.handle.net/21.15107/rcub_smile_2096 .

TY  - JOUR
AU  - Perić, Tamara
AU  - Marković, Dejan
AU  - Petrović, Bojan
AU  - Radojević, Vesna J.
AU  - Todorović, Tatjana
AU  - Anđelski-Radičević, Biljana
AU  - Jančić-Heinemann, Radmila M.
AU  - Susić, Gordana
AU  - Peri'-Popadić, Aleksandra
AU  - Tomić-Spirić, Vesna
PY  - 2015
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1998
AB  - The purpose of this study was to evaluate efficacy of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and casein phosphopeptide-amorphous calcium fluoride phosphate (CPP-ACFP) containing pastes among individuals with Sjogren's syndrome (SS). Thirty patients were randomised into three groups: CPP-ACP, CPP-ACFP, and 0.05 % NaF to be used two times a day during a 28-day experimental period. Saliva was analysed for flow rate, pH, buffering capacity and mineral concentrations. Dental plaque was examined for pH. Following the formation of artificial carious lesion, participants wore enamel slabs for an in situ remineralisation study. Remineralisation potential was examined using scanning electron microscope (SEM) and energy dispersive spectroscopic (EDS) technique. SE microphotographs were subsequently analysed for area, diameter, perimeter, roundness and the number of enamel defects and percentage of tooth surface affected by defects. At the end of the experimental period, a slight increase of salivary pH could have been observed. No differences in mineral composition of saliva were noted. The use of CPP-ACP and CPP-ACFP contributed to a significant rise of plaque pH. Image analysis revealed excessive reduction of defects' dimensions in the three experimental groups, and a decrease of the number of enamel defects in the CPP-ACP and CPP-ACFP groups. The EDS analysis did not show differences in Ca/P, Ca/O and P/O ratios in any of the treatment groups. CPP-ACP and CPP-ACFP hold promise as remineralising agents for patients with SS. Pastes containing CPP-ACP/CPP-ACFP show enhanced remineralisation potential compared with NaF mouthrinse in patients with SS.
PB  - Springer Heidelberg, Heidelberg
T2  - Clinical Oral Investigations
T1  - Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome
VL  - 19
IS  - 9
SP  - 2153
EP  - 2165
DO  - 10.1007/s00784-015-1444-1
ER  - 

@article{
author = "Perić, Tamara and Marković, Dejan and Petrović, Bojan and Radojević, Vesna J. and Todorović, Tatjana and Anđelski-Radičević, Biljana and Jančić-Heinemann, Radmila M. and Susić, Gordana and Peri'-Popadić, Aleksandra and Tomić-Spirić, Vesna",
year = "2015",
abstract = "The purpose of this study was to evaluate efficacy of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and casein phosphopeptide-amorphous calcium fluoride phosphate (CPP-ACFP) containing pastes among individuals with Sjogren's syndrome (SS). Thirty patients were randomised into three groups: CPP-ACP, CPP-ACFP, and 0.05 % NaF to be used two times a day during a 28-day experimental period. Saliva was analysed for flow rate, pH, buffering capacity and mineral concentrations. Dental plaque was examined for pH. Following the formation of artificial carious lesion, participants wore enamel slabs for an in situ remineralisation study. Remineralisation potential was examined using scanning electron microscope (SEM) and energy dispersive spectroscopic (EDS) technique. SE microphotographs were subsequently analysed for area, diameter, perimeter, roundness and the number of enamel defects and percentage of tooth surface affected by defects. At the end of the experimental period, a slight increase of salivary pH could have been observed. No differences in mineral composition of saliva were noted. The use of CPP-ACP and CPP-ACFP contributed to a significant rise of plaque pH. Image analysis revealed excessive reduction of defects' dimensions in the three experimental groups, and a decrease of the number of enamel defects in the CPP-ACP and CPP-ACFP groups. The EDS analysis did not show differences in Ca/P, Ca/O and P/O ratios in any of the treatment groups. CPP-ACP and CPP-ACFP hold promise as remineralising agents for patients with SS. Pastes containing CPP-ACP/CPP-ACFP show enhanced remineralisation potential compared with NaF mouthrinse in patients with SS.",
publisher = "Springer Heidelberg, Heidelberg",
journal = "Clinical Oral Investigations",
title = "Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome",
volume = "19",
number = "9",
pages = "2153-2165",
doi = "10.1007/s00784-015-1444-1"
}

Perić, T., Marković, D., Petrović, B., Radojević, V. J., Todorović, T., Anđelski-Radičević, B., Jančić-Heinemann, R. M., Susić, G., Peri'-Popadić, A.,& Tomić-Spirić, V.. (2015). Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome. in Clinical Oral Investigations
Springer Heidelberg, Heidelberg., 19(9), 2153-2165.
https://doi.org/10.1007/s00784-015-1444-1

Perić T, Marković D, Petrović B, Radojević VJ, Todorović T, Anđelski-Radičević B, Jančić-Heinemann RM, Susić G, Peri'-Popadić A, Tomić-Spirić V. Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome. in Clinical Oral Investigations. 2015;19(9):2153-2165.
doi:10.1007/s00784-015-1444-1 .

Perić, Tamara, Marković, Dejan, Petrović, Bojan, Radojević, Vesna J., Todorović, Tatjana, Anđelski-Radičević, Biljana, Jančić-Heinemann, Radmila M., Susić, Gordana, Peri'-Popadić, Aleksandra, Tomić-Spirić, Vesna, "Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome" in Clinical Oral Investigations, 19, no. 9 (2015):2153-2165,
https://doi.org/10.1007/s00784-015-1444-1 . .